Table 1.
Mineralocorticoid-related adverse events in abiraterone acetate-treated patients in the COU-AA-302 and COU-AA-301 registrational trials with coadministered prednisone (North American sites) versus prednisolone (European Union sites).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.